These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33095353)

  • 21. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
    Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
    J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival.
    Ong WL; Stewart J; Sahgal A; Soliman H; Tseng CL; Detsky J; Chen H; Ho L; Das S; Maralani P; Lipsman N; Stanisz G; Perry J; Lim-Fat MJ; Atenafu EG; Lau A; Ruschin M; Myrehaug S
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):750-759. PubMed ID: 38561051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping and anatomo-surgical techniques for SMA-cingulum-corpus callosum gliomas; how I do it.
    Klitsinikos D; Ekert JO; Carels A; Samandouras G
    Acta Neurochir (Wien); 2021 May; 163(5):1239-1246. PubMed ID: 33779836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.
    Hazaymeh M; Löber-Handwerker R; Döring K; Abboud T; Mielke D; Rohde V; Malinova V
    Sci Rep; 2022 Nov; 12(1):19208. PubMed ID: 36357498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.
    Patel T; Bander ED; Venn RA; Powell T; Cederquist GY; Schaefer PM; Puchi LA; Akhmerov A; Ogilvie S; Reiner AS; Moussazadeh N; Tabar V
    Neurosurgery; 2018 Jun; 82(6):808-814. PubMed ID: 28945860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resection.
    Li J; Han Z; Ma C; Chi H; Jia D; Zhang K; Feng Z; Han B; Qi M; Li G; Li X; Xue H
    Ann Clin Transl Neurol; 2024 Aug; 11(8):2176-2187. PubMed ID: 38924338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-Specific Differences in Patients with
    Gongala S; Garcia JA; Korakavi N; Patil N; Akbari H; Sloan A; Barnholtz-Sloan JS; Sun J; Griffith B; Poisson LM; Booth TC; Jain R; Mohan S; Nasralla MP; Bakas S; Tippareddy C; Puig J; Palmer JD; Shi W; Colen RR; Sotiras A; Ahn SS; Park YW; Davatzikos C; Badve C;
    AJNR Am J Neuroradiol; 2024 Sep; 45(9):1299-1307. PubMed ID: 38684319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Resection on Survival of Isocitrate Dehydrogenase 1-Mutated World Health Organization Grade II Astrocytoma After Malignant Progression.
    Grau SJ; Hampl JA; Kohl AC; Timmer M; Duval IV; Blau T; Ruge MI; Goldbrunner RH
    World Neurosurg; 2017 Jul; 103():180-185. PubMed ID: 28377251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential influence of IDH1 mutation and MGMT gene promoter methylation on glioma-related preoperative seizures and postoperative seizure control.
    Feyissa AM; Worrell GA; Tatum WO; Chaichana KL; Jentoft ME; Guerrero Cazares H; Ertekin-Taner N; Rosenfeld SS; ReFaey K; Quinones-Hinojosa A
    Seizure; 2019 Jul; 69():283-289. PubMed ID: 31141785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
    Laws ER; Parney IF; Huang W; Anderson F; Morris AM; Asher A; Lillehei KO; Bernstein M; Brem H; Sloan A; Berger MS; Chang S;
    J Neurosurg; 2003 Sep; 99(3):467-73. PubMed ID: 12959431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype.
    Patel SH; Bansal AG; Young EB; Batchala PP; Patrie JT; Lopes MB; Jain R; Fadul CE; Schiff D
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1149-1155. PubMed ID: 31248860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma.
    Massaad E; Smith WJ; Bradley J; Esposito E; Gupta M; Burns E; Burns R; Velarde JK; Berglar IK; Gupta R; Martinez-Lage M; Dietrich J; Lennerz JK; Dunn GP; Jones PS; Choi BD; Kim AE; Frosch M; Barker FG; Curry WT; Carter BS; Nahed BV; Cahill DP; Shankar GM
    Neuro Oncol; 2024 Sep; 26(9):1660-1669. PubMed ID: 38581292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    Lau D; Hervey-Jumper SL; Han SJ; Berger MS
    J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
    Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
    World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.
    Tom MC; Varra V; Leyrer CM; Park DY; Chao ST; Yu JS; Suh JH; Reddy CA; Balagamwala EH; Broughman JR; Kotagal KA; Vogelbaum MA; Barnett GH; Ahluwalia MS; Peereboom DM; Prayson RA; Stevens GHJ; Murphy ES
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1099-1105. PubMed ID: 31022510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical surgical indicators to identify candidates for radical resection of insulo-opercular gliomas.
    Kawaguchi T; Kumabe T; Saito R; Kanamori M; Iwasaki M; Yamashita Y; Sonoda Y; Tominaga T
    J Neurosurg; 2014 Nov; 121(5):1124-32. PubMed ID: 25127416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of glioblastoma in the elderly: the impact of complications.
    Karsy M; Yoon N; Boettcher L; Jensen R; Shah L; MacDonald J; Menacho ST
    J Neurooncol; 2018 May; 138(1):123-132. PubMed ID: 29392589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
    Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
    J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional-Based Resection Does Not Worsen Quality of Life in Patients with a Diffuse Low-Grade Glioma Involving Eloquent Brain Regions: A Prospective Cohort Study.
    Muto J; Dezamis E; Rigaux-Viode O; Peeters S; Roux A; Zanello M; Mellerio C; Sauvageon X; Varlet P; Oppenheim C; Pallud J
    World Neurosurg; 2018 May; 113():e200-e212. PubMed ID: 29432943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.